0001192482-14-000228.txt : 20141110 0001192482-14-000228.hdr.sgml : 20141110 20141110120757 ACCESSION NUMBER: 0001192482-14-000228 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141030 FILED AS OF DATE: 20141110 DATE AS OF CHANGE: 20141110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Paratek Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001178711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330960223 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 KNEELAND STREET STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 BUSINESS PHONE: (617) 275-0040 MAIL ADDRESS: STREET 1: 75 KNEELAND STREET STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 FORMER COMPANY: FORMER CONFORMED NAME: Transcept Pharmaceuticals Inc DATE OF NAME CHANGE: 20090130 FORMER COMPANY: FORMER CONFORMED NAME: NOVACEA INC DATE OF NAME CHANGE: 20020724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Danish BioVenture General Partner ApS CENTRAL INDEX KEY: 0001624455 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36066 FILM NUMBER: 141207478 BUSINESS ADDRESS: STREET 1: C/O GORRISSEN FEDERSPIEL, STREET 2: H.C. ANDERSENS BOULEVARD 12 CITY: COPENHAGEN STATE: G7 ZIP: 000000 BUSINESS PHONE: 617 502 6538 MAIL ADDRESS: STREET 1: C/O GORRISSEN FEDERSPIEL, STREET 2: H.C. ANDERSENS BOULEVARD 12 CITY: COPENHAGEN STATE: G7 ZIP: 000000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: K/S Danish BioVenture CENTRAL INDEX KEY: 0001623677 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36066 FILM NUMBER: 141207479 BUSINESS ADDRESS: STREET 1: C/O GORRISSEN FEDERSPIEL, H.C. STREET 2: ANDERSENS BOULEVARD 12 CITY: COPENHAGEN STATE: G7 ZIP: 00000 BUSINESS PHONE: (617) 502-6538 MAIL ADDRESS: STREET 1: C/O GORRISSEN FEDERSPIEL, H.C. STREET 2: ANDERSENS BOULEVARD 12 CITY: COPENHAGEN STATE: G7 ZIP: 00000 3 1 edgar.xml PRIMARY DOCUMENT X0206 3 2014-10-30 0 0001178711 Paratek Pharmaceuticals, Inc. PRTK 0001623677 K/S Danish BioVenture 12 H.C. ANDERSENS BLVD COPENHAGEN, DENMARK 0 0 1 0 0001624455 Danish BioVenture General Partner ApS 12 H.C. ANDERSENS BLVD COPENHAGEN, DENMARK 0 0 1 0 Common Stock 633243 D Common Stock 633243 I By Danish BV Warrant (Right to Purchase) .15 2014-04-18 2021-04-18 Common Stock 2329 D Warrant (Right to Purchase) .15 2014-04-18 2021-04-18 Common Stock 2329 I By Danish BV The Reporting Persons are part of a "group" as defined in Rule 13d-5 promulgated under the Securities Exchange Act of 1934, as amended, with the following entities and individuals: Omega Fund III, L.P.; Omega Fund III GP, L.P.; Omega Fund III GP, Ltd.; Omega Fund IV, L.P.; Omega Fund IV GP, L.P.; Omega Fund IV GP Manager, Ltd.; Omega Fund Management Limited; Sigma Holding Company; and Otello Stampacchia. This group beneficially owns, in the aggregate, 2,138,872 shares of common stock of the issuer and warrants to purchase an additional 6,412 shares of common stock of the issuer. The reported securities are held in the name of K/S Danish BioVenture ("Danish BV"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein. The reported securities are beneficially owned by Danish BioVenture General Partner ApS ("Danish BV GP"), as the general partner of Danish BV. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein. /s/ Richard Lim, authorized signatory of each Reporting Person 2014-11-10